Oaktree Acquisition Corp. III Life Sciences (OACC)
NASDAQ: OACC · Real-Time Price · USD
Oaktree Acquisition Corp. III Life Sciences currently trades with the ticker symbol OACCU
10.12
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
The company was incorporated in 2024 and is based in Los Angeles, California.
Oaktree Acquisition Corp. III Life Sciences
Country | United States |
Founded | 2024 |
IPO Date | Oct 24, 2024 |
Industry | Shell Companies |
Sector | Financials |
CEO | Zaid Pardesi |
Contact Details
Address: 333 South Grand Avenue, 28th Floor Los Angeles, California 90071 United States | |
Phone | 213 830 6300 |
Website | oaktreeacquisitioncorp.com |
Stock Details
Ticker Symbol | OACC |
Exchange | NASDAQ |
Reporting Currency | USD |
IPO Price | $10.00 |
CIK Code | 0002029769 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
John Frank | Chairman and Director |
Zaid Pardesi | Chief Executive Officer |
Aman Kumar | Director |
Mathew Pendo | Chief Operating Officer |
Courtney Conigliaro | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 11, 2024 | 8-K | Current Report |
Nov 7, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 5, 2024 | 8-K | Current Report |
Oct 31, 2024 | 8-K | Current Report |
Oct 30, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Oct 25, 2024 | 8-K | Current Report |
Oct 24, 2024 | 424B4 | Prospectus |
Oct 24, 2024 | CERT | Certification by an exchange approving securities for listing |
Oct 23, 2024 | EFFECT | Notice of Effectiveness |
Oct 23, 2024 | 8-A12B | Registration of securities |